¼¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ)Á¦17ȸ µÎ°æºÎ ¼¿ïÆ÷·³(Head and Neck Seoul Forum) : 2021-08-14±³À°ÀÏÀÚ : 2021-08-14
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°(½Ç½Ã°£ È»ó °ÀÇ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)Á¦17ȸ µÎ°æºÎ ¼¿ïÆ÷·³(Head and Neck Seoul Forum)ÁÖÃÖ±â°ü : ¼¿ï¾Æ»êº´¿ø
´ã´çÀÚ : Ã־ƷÃ
¿¬¶ôó : 02-3010-3710
À̸ÞÀÏ :
ent@amc.seoul.kr ±³À°Á¾·ù : À̺ñÀÎÈÄ°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ 50,000¿ø, Àü°øÀÇ 40,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 09:00~09:20 Cancers of oral cavity and oropharynx. Experience at Pathology Department of Asan Medical Center for 20 years Á¶°æÀÚ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 09:20~09:40 Emerging genetic landscape in head and neck squamous carcinoma À̵µ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 09:40~10:00 The role of MRI in the evaluation of oral cavity and oropharynx cancer ¹èÀ±Á¤(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 10:00~10:20 Change of epidemiology: burden of oral cavity/oropharynx cancer in Korea Á¤À¯¼®(±¹¸³¾Ï¼¾ÅÍ)
ÈÞ½Ä 08-14 ¿Â¶óÀÎ 10:20~10:40 Coffee break ()
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 10:40~10:55 Management of premalignant lesion: chemoprevention versus surgery for dysplasia of the oral cavity ÀÌ»óÁØ(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 10:55~11:10 Surgical approach: minimally invasive surgery justifies for all? Á¤¿µÈ£(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 11:10~11:25 Ideal surgical margin for oral cavity cancer Á¤ÇѽÅ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 11:25~11:40 Extent of neck dissection (elective versus therapeutic neck dissection for clinically node negative early oral cancer) ÃÖÀÍÁØ(¿øÀڷº´¿ø)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 11:40~11:55 Efficacy of salvage surgery for recurrent cancer ÀÌÀ±¼¼(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 11:55~12:10 Reconstruction for advanced oral cavity/oropharynx cancer Á¤ÀºÀç(¼¿ïÀÇ´ë)
½Ä»ç 08-14 ¿Â¶óÀÎ 12:10~13:10 Lunch ()
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 13:10~13:30 Therapy de-intensification in HPV (+) oropharyngeal cancer ÀÌ»ó¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 13:30~13:50 Personalized targeted therapy and immunotherapy in head and neck squamous cell carcinoma ±è¹ü¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 13:50~14:05 Evaluation of QoL after oropharyngeal cancer treatment Á¤¸¸±â(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 14:05~14:20 Swallowing rehabilitation Â÷¿øÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 14:20~14:35 Cancer pain control ÃÖ¼º¼ö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 14:35~14:50 Follow-up after cancer treatment ¿ì½ÂÈÆ(´Ü±¹ÀÇ´ë)
ÈÞ½Ä 08-14 ¿Â¶óÀÎ 14:50~15:10 Coffee break ()
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 15:10~15:25 Surgical vs. non-surgical treatment: CUP, HPV-related cancer, & recurrent cancer ·ùÁؼ±(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 15:25~15:40 Surgical vs. non-surgical treatment: CUP, HPV-related cancer, & recurrent cancer ¼Õ¿µÀÍ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 15:40~15:55 Surgical vs. non-surgical treatment: CUP, HPV-related cancer, & recurrent cancer ¾È¼øÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 15:55~16:10 Surgical vs. non-surgical treatment: CUP, HPV-related cancer, & recurrent cancer À̸íö(¿øÀڷº´¿ø)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 16:10~16:20 Surgical vs. non-surgical treatment: CUP, HPV-related cancer, & recurrent cancer Á¤ÇÊ»ó(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 08-14 ¿Â¶óÀÎ 16:20~16:30 Surgical vs. non-surgical treatment: CUP, HPV-related cancer, & recurrent cancer ÃÖ½ÂÈ£(¿ï»êÀÇ´ë)
Åä·Ð 08-14 ¿Â¶óÀÎ 16:30~17:00 Discussion & Adjourn ()